July 17, 2026 · Form 4 insider transaction
Kreitzer Anatol sold 200 shares of MapLight Therapeutics, Inc. at $38.39 per share, a transaction worth $7.7K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 3 days after the transaction.
This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 24, 2025.